State "right to try" laws can give terminally ill patients early access to experimental drugs and medical devices — but they arguably make safety and efficacy secondary to speedy access.
Former Secretary of State James A. Baker, III, testified on May 12, 2016, before the Senate Committee on Foreign Relations on America's role in the world.
This working paper analyzes the prospects of Iran changing its domestic and foreign policy behavior over the longer term, and outlines what the United States and others can do to promote such changes.
This blog post examines how Donald Trump's status as the presumptive GOP presidential nominee could impact Texas Republicans running for offices in the November general elections.
The authors discuss the road ahead in Mexico City's restructuring as well as the challenges that remain to ensure that the city gains more political and fiscal autonomy in this post on the Baker Institute Blog.
High cancer drug prices reduce access to therapy, cause treatment abandonment and financial bankruptcies, as well as severe emotional and family distress.
Is the U.S. better off linking its money supply to a global commodity market or allowing an independent central bank to respond to economic conditions?
Jennifer R. Herricks, postdoctoral fellow in disease and poverty, testified before the Texas House Committee on Public Health, urging the state to take the lead on developing a vaccine for the Zika virus.
The Nov. 13 terrorist attacks in Paris have turned public opinion against allowing Syrian refugees to resettle in other countries. But rejecting refugees based on their religion or assumptions that they may assist ISIS in launching acts of terrorism betray universal values of freedom and equality.